| Name | Title | Contact Details |
|---|
OU Medicine comprises OU Medical Center, The Children`s Hospital at OU Medical Center, OU Medical Center Edmond and the OU Medicine Breast Health Network. We are Oklahoma`s largest and most comprehensive health system, offering expertise in more medical specialties than any other hospital system in the state. Some of OU Medicine`s outstanding services include Oklahoma`s highest level of trauma care for adults and children, the most advanced treatment for stroke patients, the highest-level neonatal intensive care unit (NICU) in Oklahoma, expert cardiac care at the OU Medicine Cardiovascular Institute and Children`s Heart Center, and the state`s largest group of board-certified geriatricians. OU Medical Center Edmond is home to Edmond`s only inpatient senior behavioral health program, Autumn Life Center for Geriatric Behavioral Health.Breast Health Network is the state`s largest group of dedicated breast specialists with four Oklahoma City metro locations and a statewide mobile mammography program. We have the state`s most experienced transplant team and benefit from a collaborative relationship with OU Physicians and the University of Oklahoma College of Medicine. Together, we make up OU Medicine and we`re helping keep Oklahoma alive and well.
Harnett Health System is a Dunn, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Jefferson County provides Public Health Nurses, along with Social Services. Jefferson County is served by Hospice of Central Iowa. Outpatient mental health clinics are located in Farifield. Fairfield is served by a paramedic level ambulance
Star View Community Svc is a Torrance, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.